Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis

Experimental and Molecular Pathology

Volumn 90, Issue 1, 2011, Pages 74-78

  Wei, Liu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac fibrosis; Fibroblast; MMP; Th17; Treg

Indexed keywords

COLLAGEN; CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17F; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

CARDITIS; CELL INTERACTION; CELL LINEAGE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROGENESIS; GENE EXPRESSION; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; COLLAGEN; CYTOKINES; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HEART FAILURE; HUMANS; INFLAMMATION MEDIATORS; MYOCARDITIS; MYOCARDIUM; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; VENTRICULAR REMODELING;

EID: 78650715312     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.10.004     Document Type: Review

References (65)

1. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 2007, 148(1):32-46.
2. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003, 278:1910-1914.
3. Arslan F., Smeets M.B., O'Neill L.A., Keogh B., McGuirk P., Timmers L., Tersteeg C., Hoefer I.E., Doevendans P.A., Pasterkamp G., de Kleijn D.P. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 2010, 121(1):80-90.
4. Barbul A., Regan M.C. The regulatory role of T lymphocytes in wound healing. J. Trauma 1990, 30(S97(R)):CS100.
5. Barbul A., Regan M.C. Immune involvement in wound healing. Otolaryngol. Clin. North Am. 1995, 28:955-968.
6. Casini A., Ricci O.E., Paoletti F., Surrenti C. Immune mechanisms for hepatic fibrogenesis. T-lymphocyte-mediated stimulation of fibroblast collagen production in chronic active hepatitis. Liver 1985, 5:134-141.
7. Chen W., Frangogiannis N.G. The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail. Rev. 2010, 15(5):415-422.
8. Chiaramonte M.G., Donaldson D.D., Cheever A.W., Wynn T.A. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 1999, 104:777-785.
9. Chizzolini C., Parel Y., De Luca C., Tyndall A., Akesson A., Scheja A., Dayer J.M. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha. Arthritis Rheum. 2003, 48:2593-2604.
10. Claassen M.A., de Knegt R.J., Tilanus H.W., Janssen H.L., Boonstra A. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. J. Hepatol. 2010, 52(3):315-321.
11. Collins T., Krensky A.M., Clayberger C., Fiers W., Gimbrone M.A., Burakoff S.J., Pober J.S. Human cytolytic T lymphocyte interactions with vascular endothelium and fibroblasts: role of effector and target cell molecules. J. Immunol. 1984, 133(4):1878-1884.
12. Cortez D.M., Feldman M.D., Mummidi S., Valente A.J., Steffensen B., Vincenti M., Barnes J.L., Chandrasekar B. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-β, NF-κB, and AP-1 activation. Am. J. Physiol. Heart Circ. Physiol. 2007, 293(6):H3356-H3365.
13. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
14. Datta S., Novotny M., Pavicic P.G., Zhao C., Herjan T., Hartupee J., Hamilton T. IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence. J. Immunol. 2010, 184(3):1484-1491.
15. Dubin P.J., McAllister F., Kolls J.K. Is cystic fibrosis a TH17 disease?. Inflamm. Res. 2007, 56(6):221-227.
16. Eckes B., Nischt R., Krieg T. Cell-matrix interactions in dermal repair and scarring. Fibrogenesis Tissue Repair 2010, 3:4.
17. Edwards D., Murphy G., Reynolds J., et al. Transforming growth factor β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987, 6:1899-1904.
18. Feng W., Li W., Liu W., Wang F., Li Y., Yan W. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. Exp. Mol. Pathol. 2009, 87(3):212-218.
19. Frizelle S., Schwarz J., Huber S.A., Leslie K. Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice. Am. J. Pathol. 1992, 141(1):203-209.
20. Gallily R., Stain I., Kornfeld S. Non-immune non-activated chicken macrophages destroy murine fibroblasts. Dev. Comp. Immunol. 1985, 9(4):691-699.
21. Hartupee J., Liu C., Novotny M., Li X., Hamilton T. IL-17 enhances chemokine gene expression through mRNA stabilization. J. Immunol. 2007, 179(6):4135-4141.
22. Hartupee Justin, Liu Caini, Novotny Michael, et al. IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6. J. Immunol. 2009, 182:1660-1666.
23. Huber S.A. Coxsackievirus B3-induced myocarditis: infection of females during the estrus phase of the ovarian cycle leads to activation of T regulatory cells. Virology 2008, 378(2):292-298.
24. Huber S.A. Depletion of gammadelta+ T cells increases CD4+FoxP3 (T regulatory) cell response in coxsackievirus B3-induced myocarditis. Immunology 2009, 127(4):567-576.
25. Huber S.A., Feldman A.M., Sartini D. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. Circ. Res. 2006, 99(10):1109-1116.
26. Jakubzick C., Choi E.S., Kunkel S.L., Joshi B.H., Puri R.K., Hogaboam C.M. Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts. Am. J. Pathol. 2003, 162:1475-1486.
27. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
28. Kvakan Heda, Kleinewietfeld Markus, Qadri Fatimunnisa, Park Joon-Keun, Fischer Robert, Schwarz Ines, Rahn Hans-Peter, Plehm Ralph, Wellner Maren, Elitok Saban, Gratze Petra, Dechend Ralf, Luft Friedrich C., Muller Dominik N. Regulatory T cells ameliorate angiotensin II induced cardiac damage. Circulatioin 2009, 119:2904-2912.
29. Lee J.W., Wang P., Kattah M.G., Youssef S., Steinman L., DeFea K., Straus D.S. Differential regulation of chemokines by IL-17 in colonic epithelial cells. J. Immunol. 2008, 181(9):6536-6545.
30. Leslie K.O., Schwarz J., Simpson K., Huber S.A. Progressive interstitial collagen deposition in Coxsackievirus B3-induced murine myocarditis. Am. J. Pathol. 1990, 136(3):683-693.
31. Lindsten T., June C.H., Ledbetter J.A., Stella G., Thompson C.B. Regulation of lymphokine messenger RNA stability by a surface-mediated T-cell activation pathway. Science 1989, 244:339-343.
32. Liu W., Feng W., Wang F., Li W., Zhou B., Gao C., Li Y., Kong Y., Ma M., Fu S. Adenovirus-mediated ICOSIg gene transfer alleviates cardiac remodeling in experimental autoimmune myocarditis. Immunol. Cell Biol. 2008, 86(8):659-665.
33. Marra F., Aleffi S., Galastri S., Provenzano A. Mononuclear cells in liver fibrosis. Semin. Immunopathol. 2009, 31:345-358.
34. Matsui Y., Jia N., Okamoto H., Kon S., Onozuka H., Akino M., Liu L., Morimoto J., Rittling S.R., Denhardt D., Kitabatake A., Uede T. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension 2004, 43:1195-1201.
35. Mauri C., Feldmann M., Williams R.O. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response. Arthritis Rheum. 2003, 48:839-845.
36. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003, 198:1951-1957.
37. Olson E.R., Shamhart P.E., Naugle J.E., Meszaros J.G. Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase Cdelta and intracellular calcium in adult rat cardiac fibroblasts. Hypertension 2008, 51(3):704-711.
38. Ong V.H., Carulli M.T., Xu S., Khan K., Lindahl G., Abraham D.J., Denton C.P. Cross-talk between MCP-3 and TGFbeta promotes fibroblast collagen biosynthesis. Exp. Cell Res. 2009, 315(2):151-161.
39. Parsons C.J., Takashima M., Rippe R.A. Molecular mechanisms of hepatic fibrogenesis. J. Gastroenterol. Hepatol. 2007, 22(Suppl 1):S79-S84. Review.
40. Piro M., Della Bona R., Abbate A., Biasucci L.M., Crea F. Sex-related differences in myocardial remodeling. J. Am. Coll. Cardiol. 2010, 55(11):1057-1065.
41. Qian Y., Liu C., Hartupee J., Altuntas C.Z., Gulen M.F., Jane-Wit D., Xiao J., Lu Y., Giltiay N., Liu J., Kordula T., Zhang Q.W., Vallance B., Swaidani S., Aronica M., Tuohy V.K., Hamilton T., Li X. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 2007, 8(3):247-256.
42. Quercioli A., Mach F., Montecucco F. Novel treatment strategy with direct renin inhibition against heart failure. Panminerva Med. 2010, 52(1):41-51.
43. Reiner S.L. Development in motion: helper T cells at work. Cell 2007, 129(1):33-36.
44. Riad A., Jäger S., Sobirey M., Escher F., Yaulema-Riss A., Westermann D., Karatas A., Heimesaat M.M., Bereswill S., Dragun D., Pauschinger M., Schultheiss H.P., Tschöpe C. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J. Immunol. 2008, 180(10):6954-6961.
45. Schmidt-Weber C.B., Akdis M., Akdis C.A. TH17 cells in the big picture of immunology. J. Allergy Clin. Immunol. 2007, 120(2):247-254.
46. Seko Y., Cole S., Kasprzak W., Shapiro B.A., Ragheb J.A. The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun. Rev. 2006, 5(5):299-305.
47. Shao J., Nangaku M., Miyata T., Inagi R., Yamada K., Kurokawa K., Fujita T. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003, 42:31-38.
48. Shen F., Gaffen S. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 2008, 41(2):92-104.
49. Shi Z., Wakil A.E., Rockey D.C. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc. Natl Acad. Sci. USA 1997, 94:10663-10668.
50. Shishido T., Nozaki N., Yamaguchi S., Shibata Y., Nitobe J., Miyamoto T., Takahashi H., Arimoto T., Maeda K., Yamakawa M., Takeuchi O., Akira S., Takeishi Y., Kubota I. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 2003, 108(23):2905-2910.
51. Shvu K.G., Wang B.W., Chen W.I., Kuan P., Huang C.R. Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts. Eur. J. Heart Fail. 2010, 12(3):219-226.
52. Taflin C., Mivara M., Nochy D., Valevre D., Naccache J.M., Altare F., Salek-Pevron P., Badoual C., Bruneval P., Haroche J., Mathian A., Amoura Z., Hill G., Gorochov G. FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am. J. Pathol. 2009, 174(2):497-508.
53. Therapondos G., Flapan A.D., Dollinger M.M., Garden O.J., Plevris J.N., Hayes P.C. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. Liver Transpl. 2002, 8:690-700.
54. Thornton A.M., Shevach E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 2000, 164:183-190.
55. Thornton A.M., Piccirillo C.A., Shevach E.M. Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur. J. Immunol. 2004, 34:366-376.
56. Vaillant B., Chiaramonte M.G., Cheever A.W., Soloway P.D., Wynn T.A. Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J. Immunol. 2001, 167:7017-7026.
57. Walter M.N., Wright K.T., Fuller H.R., Macneil S., Johnson W.E. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Exp. Cell Res. 2010, 316(7):1271-1281.
58. Wynn T. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214(2):199-210.
59. Yang F., Liu Y.H., Yang X.P., Xu J., Kapke A., Carretero O.A. Myocardial infarction and cardiac remodelling in mice. Exp. Physiol. 2002, 87(547 (R)):C555.
60. Yates C.C., Krishna P., Whaley D., Bodnar R., Turner T., Wells A. Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring. Am. J. Pathol. 2010, 176(4):1743-1755.
61. Yip G.W., Fung J.W., Tan Y.T., Sanderson J.E. Hypertension and heart failure: a dysfunction of systole, diastole or both?. J. Hum. Hypertens. 2009, 23(5):295-306.
62. Yu Q., Watson R.R., Marchalonis J.J., Larson D.F. A role for T lymphocytes in mediating cardiac diastolic function. Am. J. Physiol. Heart Circ. Physiol. 2005, 289(2):H643-H651.
63. Yu Q., Horak K., Larson D.F. Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension 2006, 48:98-104.
64. Zhang Y., Xu R. Myocardial fibrosis: a new target for heart failure therapy. Zhonghua Yi Xue Za Zhi 2006, 86(17):1155-1157.
65. Zhu J., Yamane H., Paul W.E. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 2010, 28:445-489.